- Home
- CMBM vs GDTC Comparison
CMBM vs GDTC Comparison
Compare CMBM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- GDTC
- Stock Information
- Founded
- CMBM 2011
- GDTC 2018
- Country
- CMBM United States
- GDTC Singapore
- Employees
- CMBM N/A
- GDTC N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- GDTC Health Care
- Exchange
- CMBM Nasdaq
- GDTC Nasdaq
- Market Cap
- CMBM 18.6M
- GDTC 21.5M
- IPO Year
- CMBM 2019
- GDTC 2023
- Fundamental
- Price
- CMBM $0.72
- GDTC $2.18
- Analyst Decision
- CMBM Buy
- GDTC Buy
- Analyst Count
- CMBM 1
- GDTC 1
- Target Price
- CMBM $3.00
- GDTC $5.00
- AVG Volume (30 Days)
- CMBM 173.4K
- GDTC 13.2K
- Earning Date
- CMBM 11-06-2025
- GDTC 01-01-0001
- Dividend Yield
- CMBM N/A
- GDTC N/A
- EPS Growth
- CMBM N/A
- GDTC N/A
- EPS
- CMBM N/A
- GDTC N/A
- Revenue
- CMBM $172,215,000.00
- GDTC $368,838.00
- Revenue This Year
- CMBM N/A
- GDTC $5.37
- Revenue Next Year
- CMBM $17.73
- GDTC N/A
- P/E Ratio
- CMBM N/A
- GDTC N/A
- Revenue Growth
- CMBM N/A
- GDTC N/A
- 52 Week Low
- CMBM $0.23
- GDTC $1.20
- 52 Week High
- CMBM $2.08
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- CMBM 49.46
- GDTC 63.22
- Support Level
- CMBM $0.62
- GDTC $1.82
- Resistance Level
- CMBM $0.77
- GDTC $2.27
- Average True Range (ATR)
- CMBM 0.06
- GDTC 0.09
- MACD
- CMBM 0.00
- GDTC 0.03
- Stochastic Oscillator
- CMBM 44.10
- GDTC 80.00
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.